Cancer Series Module 1: Impact of Psychosocial Aspects of Cancer on Occupational Engagement
Sorry! Image not available at this time

SKU: OL50

Publisher: AOTA Continuing Education

Published: 2015

Download
$49.95
Basic Member Price
Non-Member Price: $64.95

Product Overview

Get an AOTA Digital Badge on Cancer Rehabilitation to share your learning accomplishment when you complete the required CE.

Get details here

Authors: Kathleen Lyons, ScD, OTR and Series Editors: Claudine Campbell, MOT, OTR, CLT & Lauro Munoz, MOT, OTR, CHC

Earn .15 CEU (NBCOT 1.88 PDUs/1.5 contact hours)

Module Description

Being diagnosed with and treated for cancer can create a number of psychosocial challenges and opportunities.  This module, the first in AOTA’s Cancer Series, addresses 3 psychosocial challenges (distress, depression, and anxiety) and 3 psychosocial opportunities (lifestyle changes, spiritual growth, and life completion) that may occur within the context of cancer.  The first half of the module examines each aspect, including definition, prevalence, screening tools, and evidence-based approaches used by members of the oncology team.  The second half of the module focuses on ways to assess the impact of psychosocial aspects on occupational engagement, and treatment strategies that can be used by occupational therapy practitioners in a variety of settings.

·       Mobile Access – this course is easily viewed on a tablet making your learning portable and facilitating on-the-job access to resources.

Learning Objectives

After completing this module, you will be able to:

  • Discuss the psychosocial impact of cancer upon the client’s well-being and ability to participate in daily activities.
  • Identify appropriate assessments to screen for and evaluate the effects of distress, anxiety, and depression on the occupational engagement of adults with cancer.
  • Describe occupational therapy intervention strategies to reduce distress, depression, and anxiety and to promote psychosocial growth and well-being of adults with cancer.